Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
Labcorp, FDA and Charles River Collaborate to Advance Drug Abuse Potential Assessment
The research collaboration aims to improve preclinical methods for evaluating the abuse potential of...
Read story
Otsuka’s Voyxact Demonstrates Sustained Kidney Function Preservation in Phase 3 IgAN Trial
Two-year VISIONARY results showed a 97.1% lower risk of composite kidney outcome events and sustaine...
Read story
Lumen Bioscience Reports Positive Phase 2 Results for Oral LMN-201 in C. difficile Infection
Investigational biologic LMN-201 achieved an 83.3% global cure rate and a six-fold reduction in infe...
Read story
Roche Reports Promising Phase III Fenebrutinib Results in Multiple Sclerosis
Investigational therapy reduced chronic active brain lesion markers and annualised relapse rates, wh...
Read story
Paradigm Therapeutics Enrolls First Patient in Phase 3 Trial of SD-101 for Epidermolysis Bullosa
Paradigm Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatm...
Read storyPage 1 of 2
